Aripiprazole vs Risperidone for the acute-phase treatment of first-episode psychosis: A 6-week randomized, flexible-dose, open-label clinical trial-Reference-Cited by-同舟云学术

Aripiprazole vs Risperidone for the acute-phase treatment of first-episode psychosis: A 6-week randomized, flexible-dose, open-label clinical trial

Published:2021-06 Issue: Volume:47 Page:74-85
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Gómez-Revuelta Marcos,Pelayo-Terán José María,Vázquez-Bourgon Javier,Ortiz-García de la Foz Víctor,Mayoral-van Son Jacqueline,Ayesa-Arriola Rosa,Crespo-Facorro Benedicto

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference51 articles.

1. Assessing depression in schizophrenia: the Calgary depression scale;Addington;British J. Psychiatry,1993

2. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected;Agid;Arch. Gen. Psychiatry,2003

3. Correlational studies of the scale for the assessment of negative symptoms and the scale for the assessment of positive symptoms: an overview and update;Andreasen;Psychopathology,1995

4. The Scale for the assessment of positive symptoms (SAPS);Andreasen;Univ Iowa,1984

5. Scale for the assessment of negative symptoms (SANS);Andreasen;Br J Psychiatry,1989

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis;Pharmacy;2023-11-10

2. Efficacy of transcutaneous electrical acupoint stimulation for patients with first-episode schizophrenia: An 8-week, preliminary, randomized controlled trial;Psychiatry Research;2023-07

3. Biological evaluation and in silico studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment;Frontiers in Pharmacology;2023-04-21

4. Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial;International Journal of Neuropsychopharmacology;2022-07-27

5. Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis;International Journal of Neuropsychopharmacology;2022-05-31